Global Scans · Brain Technologies · Weekly Summary

• Hormonal contraception used by millions of women worldwide has been linked to an increased risk of developing a rare type of brain tumour. Sky News
• A newly published study by French researchers is the first to associate the extended use of certain progestogens and an increased risk of a brain tumour called intracranial meningioma, which accounts for 40% of primary tumours of the central nervous system. New Atlas
• In the near future, AAC devices will be combined with non-invasive methods of access to the brain-computer interface, which will revolutionize communication. PubMed Central (PMC)
• At Michigan Medicine, doctors and researchers are using artificial intelligence to help diagnose brain tumours, generate new antiviral molecules, and analyze cardiac signals to better predict adverse cardiac events. Michigan Today
• The Allen Institute plans to leverage generative AI to help researchers simulate brain processes and speed up discoveries. Forbes
• Researchers at Julich are already using Nvidia GPUs in existing systems to run quantum simulations and will plug neuromorphic and quantum computers into Jupiter. HPCwire
• Some benign brain tumours do not cause problems and may not require treatment, while others come with a high mortality risk within a few years if they become cancerous. Healthline Media
• Neuralink's technology will mainly work through an implant called the Link - a device about the size of five stacked coins that is placed inside the human brain through invasive surgery. The National
• CAA could increase the risk of microbleeds that develop in the brains of some people with Alzheimer's who are treated with antibodies to remove amyloid. Scientific American
• The recent news that Elon Musk's Neuralink project has successfully implanted a brain-computer interface into a human subject's brain gives an indication of the types of technologies we can expect to see in the short and long-term future. Innovation in Business
• Researchers are studying biomarkers (biological signs of disease found in brain images, cerebrospinal fluid, and blood) to detect early changes in the brains of people with MCI and in cognitively normal people who may be at greater risk for Alzheimer's. National Institute on Aging
• Cedars-Sinai will explore in-space production of stem cells into heart, brain, and blood tissues in support of regenerative medicine uses on Earth. NASA
• Diabetic patients who take anti-diabetic drugs - known as glitazones - long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found. University of Bristol
• New research by the University of Sussex could help to increase life expectancy and improve treatment for an aggressive brain cancer, which impacts thousands of people every year in the UK, and hundreds of thousands worldwide. ScienceDaily
• The demonstrator project, will test the brains of the BAE Systems military XLAUV on one of Cellula Robotics' underwater vehicles in trials set to take place in 2025 at a facility on the south coast of England. Cellula Robotics
• Scientists at Tsinghua University in China have made a big breakthrough in neural technology by creating the Neural Electronic Opportunity, a wireless brain-computer interface implant. BOL NEWS
• UK scientists are to carry out studies on a new breakthrough blood test which could be used to detect certain types of brain cancer. Sky News
• Neuralink, with the majority ownership of Elon Musk, develops devices that it hopes can help individuals with severe brain damage or physical disabilities. Aragon Research
• In 2024, we can anticipate breakthroughs in fields like quantum computing, biotechnology, brain-computer interfaces, and artificial intelligence that push the boundaries of what was once deemed possible. Dr Mark van Rijmenam, CSP | Strategic Futurist Speaker
• Repeated sessions might lead to longer-term changes in brain cells, enhancing their activity levels and potentially affecting multiple brain regions associated with depression. University of East London
• Researchers are transplanting dopaminergic stem cells into the brains of patients with moderate Parkinson's disease and are expected to have preliminary results by 2024. Breaking Latest News
• As a frontrunner in the neurotech industry, Emotiv India continues to drive innovation and unlock the potential of the human brain for various applications, shaping the future of neuroscience and technology. Inventiva
• In the realm of technology, few innovations hold as much promise and potential as the Brain-Computer Interface (BCI). https://www.factmr.com

Last updated: 14 April 2024